Scroll Top

DIASORIN

Stand assembly in Granada for Diasorin. SEIMC Congress. Design, manufacture and assembly of a small stand by Tensegrity Stands.

Diasorin is a world leader in the laboratory diagnostics market, specializing in the immunodiagnostics and molecular diagnostics segments.
In addition, for more than 50 years busy with diagnosis to help doctors and patients make better decisions at the most important moments.
Diagnosis is, in fact, the first step in knowing the state of a person’s health: that’s why our tests can make a difference.
Its precision and reliability allow the early diagnosis of different diseases to millions of people, who will be able to undertake the appropriate clinical pathway.

The stand assembly in Granada, at the XXV Congress of the Spanish Society of Infectious Diseases and Clinical Microbiology, was held in person in Granada from June 2 to 4, 2022.

The SEIMC congress is the Congress of the Spanish Society of Infectious Diseases and Clinical Microbiology.

As is well known, Granada is a unique, welcoming city steeped in history. Its streets, its typical neighborhoods such as the Albaicín, the Sacromonte, the Alcaicería, the surroundings of the Alhambra, or the historic center will be an incentive for your attendance.

How was the stand in Granada made for Diasorin?

Discover all our creative stands in our portfolio. Other small stands with design are, for example: Sedecal, or more recently, for Alfasigma. We also have another example with the modular stand for Bloss.

Diasorin are global leader in the laboratory diagnostics market, specializing in the immunodiagnostics and molecular diagnostics segments.
For over 50 years we have been dealing with diagnostics to help physicians and patients make better decisions in the most important moments.
Diagnosis is, in fact, the first step to become aware of a person’s state of health: this is why our tests can make the difference.
Their precision and reliability allow the early diagnosis of different diseases for millions of people, who will be able to undertake the appropriate clinical pathway.